SynthesisBlood advances2023

Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis.

Mia Djulbegovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.